Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-11-25

Clinical Trial Update: Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia. [Phase 2]

View source ↗

Summary

This document reports the completion and posting of results for a Phase 2 exploratory trial of degarelix in benign prostatic hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Firmagon (Degarelix)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: BPH | Phase 2 | Status: COMPLETED | Results posted: 2010-11-25